[Proposal for a diagnostic and therapeutic care pathway of the Piedmont Region on lipid-lowering and antithrombotic treatment in patients with peripheral arterial disease]

G Ital Cardiol (Rome). 2023 May;24(5):344-354. doi: 10.1714/4026.40008.
[Article in Italian]

Abstract

The aim of this paper is to present the diagnostic and therapeutic care pathway on peripheral arterial disease, recently developed in the Piedmont Region, Italy. It proposes a combined approach between the cardiologist and vascular surgeon for optimizing the treatment of patients with peripheral artery disease, which includes the most recently approved antithrombotic and lipid-lowering drugs. The goal is to promote a greater awareness on peripheral vascular disease, in order to implement its treatment patterns and consequently to perform an effective secondary cardiovascular prevention.

Publication types

  • English Abstract

MeSH terms

  • Critical Pathways
  • Fibrinolytic Agents* / therapeutic use
  • Humans
  • Hypolipidemic Agents / therapeutic use
  • Lipids
  • Peripheral Arterial Disease* / diagnosis
  • Peripheral Arterial Disease* / drug therapy

Substances

  • Fibrinolytic Agents
  • Hypolipidemic Agents
  • Lipids